Skip to content

A clinical study to evaluate effectiveness of karanjadi lepa in dadru with special referance to bahihparimarjan chikista siddhant (when locally applied)

A single arm clinical study to evaluate efficacy of karanjadi lepa in dadru with special referance to bahihparimarjan chikista siddhant - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057030
Enrollment
60
Registered
2023-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient will be diagnosed on the basis of signs and symptoms of dadru kushta as per mentioned in classical text All types of tinea will be included Less chronic than 3 years

Exclusion criteria

Exclusion criteria: Patient suffering from major systemic disorder and immunocompramise disorder Patient having patches due to burn, chemical exposure

Design outcomes

Primary

MeasureTime frame
Decreaaed signs and symptoms of disease such as itching,redness,number of patches,size of patches after treatmentTimepoint: 4 weeks

Secondary

MeasureTime frame
the efficacy of Karanjadi Lepa in Dadru even after the stoppage of the treatmentTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr. Nilesh Kulkarni

Sumatibhai Shah Ayurveda Mahavidyalay, Hadapsar

prof.dr.nileshkulkarni@gmail.com8805335512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026